List of Excipients in API olanzapine and samidorphan l-malate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing olanzapine and samidorphan l-malate
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Alkermes Inc | LYBALVI | olanzapine and samidorphan l-malate | 65757-651 | CELLULOSE, MICROCRYSTALLINE | 2031-08-30 |
Alkermes Inc | LYBALVI | olanzapine and samidorphan l-malate | 65757-651 | CROSPOVIDONE | 2031-08-30 |
Alkermes Inc | LYBALVI | olanzapine and samidorphan l-malate | 65757-651 | FERRIC OXIDE YELLOW | 2031-08-30 |
Alkermes Inc | LYBALVI | olanzapine and samidorphan l-malate | 65757-651 | HYPROMELLOSE | 2031-08-30 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for olanzapine and samidorphan l-malate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
olanzapine and samidorphan l-malate drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
>Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
olanzapine and samidorphan l-malate drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
>Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
olanzapine and samidorphan l-malate drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
>Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
olanzapine and samidorphan l-malate drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
>Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
olanzapine and samidorphan l-malate drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
>Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
olanzapine and samidorphan l-malate drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
>Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
olanzapine and samidorphan l-malate drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
>Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
olanzapine and samidorphan l-malate drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
>Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
olanzapine and samidorphan l-malate drug variants containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
>Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.